📰Actualité dans le Bulletin des médecins suisses : ANRESIS se présente avec ses nouveaux outils ! Vous y découvrirez comment nous soutenons les professionnels de santé avec des outils importants pour le bon usage des antibiotiques anresis.ch/wp-content/upl…

📰Aktuell in der Schweizerischen Ärztezeitung: ANRESIS stellt sich und seine neuen Tools vor! Wie wir die Ärzteschaft mit dem ANRESIS-guide und weiteren Anwendungen beim richtigen Einsatz von Antibiotika unterstützen anresis.ch/wp-content/upl…

ANRESIS was featured in the SRF - Schweizer Radio und Fernsehen daily News Plus podcast on the topic "Antibiotic resistance: how big is the problem in Switzerland?" srf.ch/audio/news-plu…

ANRESIS was present at this year's ESCMID Global congress with posters on the WHO target of 60% Access group antibiotics reached by Switzerland (anresis.ch/wp-content/upl…) and on extended-spectrum cephalosporin resistances during the COVID-19 pandemic (anresis.ch/wp-content/upl…).

ANRESIS contributed to posters during the 2024 congress SGAIM SSMIG including one presented by Sereina M. Graber and others on the contribution of the different prescribers to the overall outpatient antimicrobial consumption anresis.ch/wp-content/upl…. Congratulations on your work!

🗞️ Antibiotikaresistenzen: Der Bundesrat hat den neuen #OneHealth-Aktionsplan 2024–2027 im Rahmen der Strategie Antibiotikaresistenzen Schweiz (StAR) verabschiedet. Dieser sieht einen kollektiven Ansatz vor BLV - OSAV - USAV BLW - OFAG - UFAG BAFU - OFEV - UFAM - FOEN 👇 bag.admin.ch/bag/de/home/da…

🗞️ Résistance antibiotique : le Conseil fédéral a adopté le nouveau plan d’action #OneHealth 2024-2027, dans le cadre de la Stratégie Antibiorésistance Suisse (StAR). Il propose une approche collective BLV - OSAV - USAV BLW - OFAG - UFAG BAFU - OFEV - UFAM - FOEN 👇 bag.admin.ch/bag/fr/home/da…

🗞️ Resistenze agli antibiotici: il Consiglio federale ha adottato il nuovo piano d’azione #OneHealth 2024–2027 della Strategia nazionale contro le resistenze agli antibiotici (StAR), che propone un approccio collettivo tra BLV - OSAV - USAV BLW - OFAG - UFAG BAFU - OFEV - UFAM - FOEN 👇 bag.admin.ch/bag/it/home/da…

📰Read our latest study on how the COVID-19 pandemic affected ESCR E. coli and K. pneumoniae bloodstream infections in Switzerland. anresis.ch/wp-content/upl…

Antibiotic use also matters for C. difficile incidence rates. Learn more from the ANRESIS poster at the Joint Annual Meeting of SSI/SSM/SSHH 2024 in Bern. anresis.ch/wp-content/upl…

In a programme on Swiss radio SRF it was discussed why we should pay attention to global AMR trends and the situation in animals. With insights from ANRESIS. Tune in now! anresis.ch/wp-content/upl… (German, SRF Wissenschaftsmagazin 28.9.24)

🦠 World #Antibiotic Awareness Week #WAAW: The India-specific version of the @ANRESIS Guide from #unibern provides an overview of #resistance situation in North and West India, laying the groundwork for greater awareness: sohub.io/2y10. BAG – OFSP – UFSP

🗞️ Der neue Swiss Antibiotic Resistance Report 2024 (SARR) zeigt, dass der Einsatz von Antibiotika weiterhin rückläufig ist 👇 bag.admin.ch/bag/de/home/da… #WAAW #AntimicrobialResistance

🗞️ Le nouveau Swiss Antibiotic Resistance Report 2024 (SARR) montre que l’utilisation d’antibiotiques continue de baisser 👇 bag.admin.ch/bag/fr/home/da… #WAAW #AntimicrobialResistance

🗞️ Il nuovo Swiss Antibiotic Resistance Report (SARR) 2024 rivela che l’uso di antibiotici è in continua diminuzione 👇 bag.admin.ch/bag/it/home/da… #WAAW #AntimicrobialResistance

Our latest study on Pseudomonas aeruginosa bloodstream infections in Switzerland (2010-2022) reveals increasing incidence and antibiotic resistance. Notably, we observed a high incidence in elderly, while resistance rates were elevated in young patients. anresis.ch/wp-content/upl…

ANRESIS participated in this year’s #ESCMID Global Congress, presenting research on outpatient antibiotic use (anresis.ch/wp-content/upl…), Candida infections (anresis.ch/wp-content/upl…), and nosocomial respiratory pathogens (anresis.ch/wp-content/upl…).

A new study based on ANRESIS data shows an association between antimicrobial consumption and C. difficile incidence in a Swiss medical centre. anresis.ch/wp-content/upl…

What does the AMR situation in India look like – and how is Switzerland connected? A compelling report by SRF’s Trendmagazine explores the global dynamics of antimicrobial resistance (in German). srf.ch/audio/trend/ge…

This article summarizes 20 years of ANRESIS—from data collection to the development of interactive tools (in German): anresis.ch/wp-content/upl…